Human Milk Oligosaccharides Market Report

Human milk oligosaccharide is a bioactive complex sugar molecule, which promotes growth of healthy bacteria, such as bifid bacteria genus in human gut. It also and helps improve metabolic activity in human body. Incorporation of HMO in the formulation of functional foods and beverages not only promotes growth of healthy bacteria but also eliminates harmful microbes such as salmonella, listeria, and campylobacter. HMOs signify the next frontier in infant nutrition as they consists of a major component of the immune-protection conferred by breast milk upon vulnerable infants. Progress in clinical research has regarded supplementary provision of HMOs an appealing option for new-borns who cannot be breast-fed. Presence of numerous major  companies and resultant competition in this sector is likely to facilitate the usage of HMO in infant formula over the forecast period, boosting the market growth.

Human Milk Oligosaccharides Market Dynamics

The increasing proportion of women in employment, low breastfeeding rate in various region, coupled with increasing application areas of human milk oligosaccharide are the key drivers of human milk oligosaccharide market. Besides, high demand of dietary supplement owing to increased health consciousness and growing campaigns to promote breastfeeding, milk formula are among the key reasons behind the growth of the human milk oligosaccharide market. The market is also driven by the various health benefits of the HMOs. The combined prebiotic, antimicrobial, and antiadhesive effects of HMOs support to shaping the infant gut microbiome early in life, reducing the risk of acute diseases also that of non-communicable diseases such as asthma and allergic diseases. The shift in lifestyles focusing towards nutritious food will boost the product demand. 

Human Milk Oligosaccharides Market Segmental Overview

The report analyses the human milk oligosaccharides market based on product, application, and geography. 

Human Milk Oligosaccharides Market by Product 

The various HMO products are commercially available in the market including fucosyllactose, sialyllactose and lacto-n-neotetraose (LNnT) & lacto-n-tetraose (LNT).  Among all these product types, fucosyllactose segment is the largest segment with close to 50% market share in the global human milk oligosaccharides market. 2'-FL is the most abundant oligosaccharide in human milk, making up around 20% to 30% of all oligosaccharides in human milk. 2'-FL is considered to play a crucial role in protecting and promoting the health of newborn infants. Analogues of the oligosaccharide 2'-fucosyllactose (2'-FL) found in human milk have only become commercially available relatively recently. Addition of 2’ Fucosyllactose in infant have been gaining popularity in the recent past as an infant formula ingredient to cater to the demands of the baby nutrition segment

Human Milk Oligosaccharides Market Application 

The human milk oligosaccharides market finds application in infant formula, functional food & beverages, food supplements etc. HMOs are one of the major differences between cow’s milk and human milk, and available evidence indicates that these components do have a health promoting benefit in human milk. The addition of one or two of these components to infant formula is safe and brings infant formula closer to human milk. HMOs have many different roles to play for the infant. HMOs also directly modulate host-epithelial responses, favoring reduced binding of pathogenic microbiota to the gut epithelium. Rise in the populations, increasing disposable income of people in developing regions. In addition, rapid urbanization and the growth of the middle class have propelled the infant formula market

Human Milk Oligosaccharides Market by Geography 

Geographically, the global Human Milk Oligosaccharides market can be distributed into North America, Europe, Asia Pacific, and Rest of the world which include Latin America, and Middle East & Africa. Countries considered in North America region include USA, Canada, and Mexico. Whereas, Europe covers Germany, Italy, Spain, France, UK and Rest of Europe (RoE).  Major countries covered in Asia Pacific include Japan, India, China and Rest of the Asia Pacific. Increasing world population is the key factor drawing the growth of the HMO market. According to the WHO, the total world population is estimated reach 9.5 billion by 2050. This rise in population will play an instrumental role in the growth of the market. Moreover, with growing present population sedentary lifestyle, North America held the major market share of the market in 2019 and it is expected to observe substantial growth of human milk oligosaccharides market

Market Key Players 

The key competitors of this market include Abbott Inc.(United states), FrieslandCampina(Netherlands), DuPont de Nemours Inc.(United States), Inbiose(Europe), Glycosyn(New Zealand), ZuChem(united states), Jennewein Biotechnologie(Germany), Glycom(Denmark), Medolac Laboratories(United states), Dextra Laboratories(United Kingdom) and  ProZyme Inc(United states) among others.